It was found that stiffer matrices stopped the production of PGE2 and mediators in its pathway (COX-2, PTGES) pointing to potentially lower levels of PGE2 in the lungs of IPF patients [109]. The gene discussed is PTGS2; the disease is idiopathic pulmonary fibrosis.